Conventional disease-modifying anti-rheumatic drugs combined with Chinese Herbal Medicines for rheumatoid arthritis: A systematic review and meta-analysis

10.1016/j.jtcme.2022.01.005

Rong Han；Hong Cheng Ren；Sitong Zhou；Sherman Gu；Yue-Yu Gu；Daniel Man-yuen Sze；Meng-Hua Chen

Chinese herbal medicine ； Rheumatoid arthritis ； Conventional disease-modifying anti-rheumatic drugs ； Adverse event ； Efficacy

Journal of Traditional and Complementary Medicine

12卷5期（2022 / 09 / 01）

437 - 446

英文

Rheumatoid Arthritis (RA) remains a major global public health challenge. Disease-modifying anti-rheumatic drugs (DMARDs) are standard therapeutic drugs for RA. Conventional DMARDs (c-DMARDs) are a subgroup of approved synthetic DMARDs. The c-DMARDs experienced lesser response with longer disease duration or drug exposure, and unwanted adverse events (AEs). The combination treatments (CTs) of c-DMARDs and Chinese Herbal Medicines (CHMs) were often used in RA clinical trials for increasing the therapeutic effectiveness and reducing the AEs. This systematic review aimed to evaluate the efficacy and safety of the CTs for RA. Databases were searched from inception to October 2020 for identification of randomized controlled trials (RCTs) that investigated the CTs in the management of RA. Twenty-three RCTs with 2,441 participants were included. The assessments and analyses found CTs improved American College of Rheumatology (ACR) 20 (RR: 1.33, 95% CI [1.21, 1.45], 10 studies, n=1,075) and alleviated AEs (RR: -0.40, 95% CI [-0.30, -0.53], 19 studies, n=2,011) in comparison with c-DMARDs. The CTs also significantly improved RA symptoms and patient-reported outcomes; reduced disease activity score (DAS) 28, serum acute-phase reactants and RA biomarkers. The five most commonly used herbs in included studies were Angelicae Sinensis Radix, Paeoniae Radix Alba, Cinnamomi Ramulus, Glycyrrhizae Radix et Rhizoma, and Clematidis Radix et Rhizoma. Pharmacological studies indicated these CHMs could contribute to the outcomes. The integrated CHMs potentially increased the overall effectiveness of c-DMARDs and alleviated AEs in management of RA. Large sample and rigorously designed RCTs are required for future studies.

1. Aletaha, D,Neogi, T,Silman, AJ(2010).Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism collaborative initiative.Arthritis Rheum,62(9),2569-2581.
2. Aletaha, D,Smolen, JS(2018).Diagnosis and management of rheumatoid arthritis: a review.JAMA,320(13),1360-1372.
3. Arnett, FC,Edworthy, SM,Bloch, DA(1988).The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis Rheum,31(3),315-324.
4. Bruce, B,Fries, JF(2003).The stanford health assessment questionnaire: dimensions and practical applications.Health Qual Life Outcome,1,20.
5. Chao, WW,Hong, YH,Chen, ML,Lin, BF(2010).Inhibitory effects of Angelica sinensis ethyl acetate extract and major compounds on NF-kappaB trans-activation activity and LPS-induced inflammation.J Ethnopharmacol,129(2),244-249.
6. Demoruelle, MK,Deane, K(2011).Antibodies to citrullinated protein antigens (ACPAs): clinical and pathophysiologic significance.Curr Rheumatol Rep,13(5),421-430.
7. Du, SG,Guo, ZH,Kong, QQ,Wang, XC,Zhou, SL,Liu, YM(2017).Effect of Sanbitang recipe in treatment of rheumatoid arthritis with kidney empty and cold-dampness symptom.Zhongguo Zhongyao Zazhi,42(14),2802-2807.
8. Efthimiou, P,Kukar, M,Mackenzie, CR(2010).Complementary and alternative medicine in rheumatoid arthritis: no longer the last resort.HSS J.,6(1),108-111.
9. Felson, DT,Anderson, JJ,Boers, M(1995).American College of RheumatologyPreliminary definition of improvement in rheumatoid arthritis.Arthritis Rheum,38(6),727-735.
10. Felson, DT,LaValley, MP(2014).The ACR20 and defining a threshold for response in rheumatic diseases: too much of a good thing.Arthritis Res Ther,16(1),101.
11. Genga, E,Moots, R,Oyoo, G(2015).DMARD use in rheumatoid arthritis: can we predict treatment response?.African J Rheumatol,3(2),50-58.
12. Gossec, L,Dougados, M,Dixon, W(2015).Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis.RMD Open,1(1),e000019.
13. Guo, Q,Wang, Y,Xu, D,Nossent, J,Pavlos, NJ,Xu, J(2018).Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.Bone Res,6,1-14.
14. Haefeli, M,Elfering, A.(2006).Pain assessment.Eur Spine J,15,17-24.
15. He, DC,Xiao, JJ(2014).Observation on the clinical efficacy and safety of Bizhenning in the treatment of rheumatoid arthritis.Modern J Integrated Tradit Chinese Western Med,23(28),3090-3092.
16. Higgins, JPT,Green, S.(2011).Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0.The Cochrane Collaboration.
17. Huang, CB,Liu, J,Chen, X(2013).Treatment of rheumatoid arthritis by Xinfeng capsule: an efficacy observation.Zhongguo Zhongxiyi Jiehe Zazhi,33(12),1599-1602.
18. Jiang, D,Wu, J(2016).Analysis and evaluation of the curative effect of Chinese medicine self-made prescription combined with anti-rheumatic drugs in the treatment of active rheumatoid arthritis.Modern Med Health,32(22),3507-3510.
19. Kang, XZ,Wu, QF,Wang, KH(2010).Efficacy of integrative medicine for the treatment of rheumatoid arthritis and its effect on glucocorticoid receptor expression.Zhongguo Zhongxiyi Jiehe Zazhi,30(12),1261-1264.
20. Li, F,Liu, B,Li, T(2020).Review of constituents and biological activities of triterpene saponins from Glycyrrhizae Radix et Rhizoma and its solubilization characteristics.Molecules,25(17)
21. Li, WY,Song, GP,Zou, YQ,He, CB(2012).Clinical observation of senile rheumatoid arthritis treated with Traditional Chinese Medicine Duhuo Jisheng decoction combined with leflunomide.Chinese Tradit Patent Med,34(6),1004-1006.
22. Li, X,Liu, JF,Zhao, GQ(2015).Clinical observation of Zhu Danxi gout prescription combined with methotrexate in the treatment of rheumatoid arthritis.Anhui Medicine,365(8),995-998.
23. Lin, CS,Yang, XY,Dai, L(2011).Multi-center clinical study on therapeutic effect of Kunxian capsule on rheumatoid arthritis.Zhongguo Zhongxiyi Jiehe Zazhi,31(6),769-774.
24. Lin, TF,Wang, L,Zhang, Y(2021).Uses, chemical compositions, pharmacological activities and toxicology of Clematidis Radix et Rhizome- a Review.J Ethnopharmacol,270,113831.
25. Liu, D,Yan, J,Yun, M(2016).Effect of Sanhuangyilong decoction plus methotrexate on tumor necrosis factor alpha and interferon gamma in serum and synovial fluid in rheumatoid arthritis patients with symptom pattern of damp heat obstruction.J Tradit Chin Med,36(5),625-633.
26. Liu, J,Zhang, Q,Li, RL(2020).The traditional uses, phytochemistry, pharmacology and toxicology of Cinnamomi ramulus: a review.J Pharm Pharmacol,72(3),319-342.
27. Lu, SJ,Shao, J,Li, XR(2002).Clinical observation on treatment of rheumatoid arthritis by combined therapy with methotrexate, sulfasalazine and Chinese herbal medicine.Zhongguo Zhongxiyi Jiehe Zazhi,22(8),571-573.
28. Lv, QW,Zhang, W,Shi, Q(2014).Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial.Ann Rheum Dis,74(6),1078-1086.
29. Moher, D,Liberati, A,Tetzlaff, J,Altman, DG,PRISMA Group(2009).Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.BMJ,339,b2535.
30. Nikiphorou, E,Radner, H,Chatzidionysiou, K(2016).Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature.Arthritis Res Ther,18(1),251.
31. Pasi, AK(2013).Herb-drug interaction: an overview.Int J Pharma Sci Res,4(10),3770-3774.
32. Putrik, P,Ramiro, S,Kvien, TK(2014).Inequities in access to biologic and synthetic DMARDs across 46 European countries.Ann Rheum Dis,73(1),198-206.
33. Qian, X,Sun, ZL,Wei, G,Guo, YK(2015).Clinical efficacy and safety of Chinese medicine decoction combined with western medicine in treatment of rheumatoid arthritis.Liaoning J Tradit Chinese Med,42(12),2371-2373.
34. Qiu, M,Zhang, Q,Chen, J(2016).Efficacy and safety assessment for treating active rheumatoid arthritis patients by integrated Traditional Chinese and Western Medicine.Chinese J Inform Tradit Chinese Med,1,31-34.
35. Ramalingam, M,Kim, H,Lee, Y,Lee, YI(2018).Phytochemical and pharmacological role of liquiritigenin and isoliquiritigenin from Radix Glycyrrhizae in human health and disease models.Front Aging Neurosci,10,348.
36. Safiri, S,Kolahi, AA,Hoy, D(2019).regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017.Ann Rheum Dis,78(11),1463-1471.
37. Sterne, J,Sutton, A,Ioannidis, J(2011).Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials.BMJ,343,4737-4307.
38. Wang, AY(2016).A clinical study on the treatment of rheumatoid arthritis with integrated Traditional Chinese and Western Medicine.Chinese Foreign Med,175-176.
39. Wang, JM,Tao, QW,Zhang, YZ,Xu, Y,Yan, XP(2013).Treating rheumatoid arthritis patients of Shen deficiency and cold invading syndrome by Bushen Quhan Zhiwang decoction combined methotrexate: an evaluation of clinical efficacy and safety.Zhongguo Zhongxiyi Jiehe Zazhi,33(5),614-618.
40. Wang, Z,Tao, XJ(2014).Treatment of rheumatoid arthritis by Yangxue Tongluo Recipe combined with immunosuppressive agents: a clinical observation.Zhongguo Zhongxiyi Jiehe Zazhi,34(3),276-278.
41. Wei, WL,Zeng, R,Gu, CM,Qu, Y,Huang, LF(2016).Angelica sinensis in China-A review of botanical profile, ethnopharmacology, phytochemistry and chemical analysis.J Ethnopharmacol,190,116-141.
42. Wu, YJ,Lao, ZY,Zhang, ZL(2001).Clinical observation on small doses Tripterygium wilfordii polyglycoside combined with methotrexate in treating rheumatoid arthritis.Zhongguo Zhongxiyi Jiehe Zazhi,21(12),895-896.
43. Xia, X,May, BH,Zhang, AL(2020).Chinese herbal medicines for rheumatoid arthritis: text-mining the classical literature for potentially effective natural products.Evid Based Complement Alternat Med,2020,7531967.
44. Xing, Q,Fu, L,Yu, Z,Zhou, X(2020).Efficacy and Safety of integrated Traditional Chinese Medicine and Western Medicine on the treatment of rheumatoid arthritis: a meta-analysis.Evid Based Complement Alternat Med,2020,4348709.
45. Xu, R.(2018).Observation on the curative effect of integrated Traditional Chinese and Western Medicine in the treatment of active rheumatoid arthritis.J Practical Tradit Chinese Med,34(1),89-90.
46. Yang, M,Guo, MY,Luo, Y(2017).Effect of Artemisia annua extract on treating active rheumatoid arthritis: a randomized controlled trial.Chin J Integr Med,23(7),496-503.
47. Yu, SY,Yu, ZA(2013).Clinical observation on 120 cases of active rheumatoid arthritis treated with compound Xiatianwu tablets.Zhongguo Zhongyao Zazhi,38(6),899-901.
48. Zhang, L,Yu, J,Wang, C,Wei, W(2019).The effects of total glucosides of paeony (TGP) and paeoniflorin (Pae) on inflammatory-immune responses in rheumatoid arthritis (RA).Funct Plant Biol,46(2),107-117.
49. Zhang, YY,Wang, J,Jiang, P,Wu, JB(2016).Efficacy of Hebi formula combined methotrexate on early rheumatoid arthritis patients with dis-harmony of gan and pi syndrome and its effects on serum MMP-3 and RANK/RANKL/OPG expressions.Zhongguo Zhongxiyi Jiehe Zazhi,36(10),1197-1201.
50. Zhao, SS,Wang, J(2012).Short-term clinical observation on compound Xiatianwu combined with methotrexate in treating rheumatoid arthritis.Zhongguo Zhongyao Zazhi,37(23),3664-3666.
51. Zhao, YX,Liu, Y(2006).Clinical observation on effects of leflunomid and total glucosides of paeony on rheumatoid arthritis.Zhongguo Zhongxiyi Jiehe Zazhi,26(4),355-357.